Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer

Update your browser to view ScienceDirect.

Request details:

Request ID: 8ebcdfa8ffbf172e-LAX
IP: 101.37.83.79
UTC time: 2024-12-02T17:00:31+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4